Specifically, for loss of Ezh2, we identify chromatin-based mechanisms and candidate genes whose derepression accelerates AML generation, and we demonstrate that its mutation confers a poor prognosis on AML patients. Here, EZH2 is linked to acute myeloid leukemia.